✦ LIBER ✦

P112 Compliance with tamoxifen and arimidex in the adjuvant treatment of women with breast cancer

✍ Scribed by V. Zille; W. Holzhauer; M. Ziller; U. Wagner; P. Hadji

Book ID: 114316025
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 62 KB
Volume: 16
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(07)70172-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

‘Arimidex’ (anastrozole) versus tamoxife

‘Arimidex’ (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview

✍ Aman U. Buzdar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Efficacy of tamoxifen following anastroz

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

✍ B. Thürlimann; J.F.R. Robertson; J.M. Nabholtz; A. Buzdar; J. Bonneterre 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 247 KB

The adjuvant treatment of elderly women

The adjuvant treatment of elderly women with breast cancer

✍ A Goldhirsch; M Colleoni; F Nole; D Crivellari; A Coates; M Castiglione-Gertsch; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Elemental composition of bone minerals i

Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen

✍ J. A. Kalef-Ezra; N. Pavlidis; G. Klouvas; A. Karantanas; I. Hatzikonstantinou; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 718 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

Tamoxifen (T) vs tamoxifen + uracil-pteg

Tamoxifen (T) vs tamoxifen + uracil-ptegafur (T + UFT) in the adjuvant treatment of postmenopausal women with node positive breast cancer

✍ L. Iglesias; A. Gómez; A. Moreno; A. Montaño; M. Ruiz; E. Calvo; P. Pastor; M. N 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 138 KB